Latest News in the pharma Industry

All

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

19 Mar 2020

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Read more 
Oxford Biomedica signs LSA with Juno Therapeutics

Oxford Biomedica signs LSA with Juno Therapeutics

19 Mar 2020

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Read more 
Univercells launches new cell and gene focused CDMO Exothera

Univercells launches new cell and gene focused CDMO Exothera

19 Mar 2020

A new contract development and manufacturing organisation to support cell and gene developers with process development and production of viral vectors has been launched by bioprocessing provider Univercells.

Read more 
Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site

Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site

17 Mar 2020

Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday.

Read more 
CPhI announces new pharma events calendar for 2020

CPhI announces new pharma events calendar for 2020

17 Mar 2020

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Read more 
Vaxxas HD-MAP to deliver vaccines directly to the skin

Vaxxas HD-MAP to deliver vaccines directly to the skin

17 Mar 2020

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

Read more 
Haselmeier receives medical device Master File Number for its injection pen systems

Haselmeier receives medical device Master File Number for its injection pen systems

17 Mar 2020

This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development.

Read more 
Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

Medicines for Europe calls for pharma supply chain remedies as COVID-19 pandemic worsens

16 Mar 2020

As the global coronavirus pandemic worsens, generics industry association Medicines for Europe has called for all available European pharmaceutical manufacturing to remain open and running at all times and highlighted the risks to the supply chain that...

Read more 
Catalent partners with Biohaven on newly-approved fast-dissolve migraine treatment

Catalent partners with Biohaven on newly-approved fast-dissolve migraine treatment

16 Mar 2020

The US Food and Drug Administration has approved migraine treatment Nurtec ODT, developed by Biohaven and using CDMO Catalent’s proprietary Zydis orally disintegrating tablet technology, the two firms said Monday.

Read more 
FDA grants EUA to Thermo Fisher’s diagnostics test for coronavirus

FDA grants EUA to Thermo Fisher’s diagnostics test for coronavirus

16 Mar 2020

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s diagnostic test for coronavirus, the contract development and manufacturing organisation said Monday.

Read more 
Technique improves drug delivery system characterization

Technique improves drug delivery system characterization

16 Mar 2020

Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.

Read more 
Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

16 Mar 2020

The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.

Read more